|
⚲
|
| Keyboard |
| Thomas Laundon | |
|---|---|
| Firm | |
| Address | 4505 Emperor Boulevard Suite 240 Durham, NC 27703 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Innocrin Pharmaceuticals Holdings LLC | 021-238335 | Executive Officer | 28.1 M of 28.1 M |
||
| Innocrin Pharmaceuticals Holdings LLC | 021-229890 | Executive Officer | 8.0 M of 14.0 M |
||
| G1 Therapeutics Inc | 021-204775 | Executive Officer | 12.6 M of 12.6 M |
||
| G1 Therapeutics Inc | 021-195183 | Executive Officer | 1.2 M of 1.2 M |
||
| PhaseBio Pharmaceuticals Inc | 021-40668 | Executive Officer | 48.5 M of 48.5 M |
||